Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerwin

Showing results (951-960 of 984) with videos related to

Pageof 99
Sort By:
Blood|May 10, 2021
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AMLBon Q Trinh, Simone Ummarino, Yanzhou Zhang, et al.
Journal of Neural Engineering|November 24, 2025
Adaptive neuromodulation dialogues: navigating current challenges and emerging innovations in neuromodulation system developmentFrederik Lampert, Matthew R Baker, Michael A Jensen, et al.
Journal of Visualized Experiments : Jove|May 24, 2021
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the WayYassine Aaboubout, Elisa M Barroso, Mahesh Algoe, et al.
Blood Advances|May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First RelapseNiek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Blood Advances|September 11, 2020
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDSGerwin Huls, Dana A Chitu, Thomas Pabst, et al.
Nature|July 22, 2014
Visualization of arrestin recruitment by a G-protein-coupled receptorArun K Shukla, Gerwin H Westfield, Kunhong Xiao, et al.
Haematologica|July 21, 2018
The phenotypic spectrum of germline <i>YARS2</i> variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2Lisa G Riley, Matthew M Heeney, Joëlle Rudinger-Thirion, et al.
Signal Transduction and Targeted Therapy|July 13, 2025
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerabilityDiego A Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, et al.
Plos One|August 12, 2022
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patientsAbraham Rutgers, Peter E Westerweel, Bronno van der Holt, et al.
Blood Cancer Journal|June 19, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabineJacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, et al.
Pageof 99

Showing results (951-960 of 984) with videos related to

Sort By:
Pageof 99
Blood|May 10, 2021
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AMLBon Q Trinh, Simone Ummarino, Yanzhou Zhang, et al.
Journal of Neural Engineering|November 24, 2025
Adaptive neuromodulation dialogues: navigating current challenges and emerging innovations in neuromodulation system developmentFrederik Lampert, Matthew R Baker, Michael A Jensen, et al.
Journal of Visualized Experiments : Jove|May 24, 2021
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the WayYassine Aaboubout, Elisa M Barroso, Mahesh Algoe, et al.
Blood Advances|May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First RelapseNiek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Blood Advances|September 11, 2020
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDSGerwin Huls, Dana A Chitu, Thomas Pabst, et al.
Nature|July 22, 2014
Visualization of arrestin recruitment by a G-protein-coupled receptorArun K Shukla, Gerwin H Westfield, Kunhong Xiao, et al.
Haematologica|July 21, 2018
The phenotypic spectrum of germline <i>YARS2</i> variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2Lisa G Riley, Matthew M Heeney, Joëlle Rudinger-Thirion, et al.
Signal Transduction and Targeted Therapy|July 13, 2025
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerabilityDiego A Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, et al.
Plos One|August 12, 2022
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patientsAbraham Rutgers, Peter E Westerweel, Bronno van der Holt, et al.
Blood Cancer Journal|June 19, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabineJacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, et al.
Pageof 99